Insulin regulates whole-body glucose homoeostasis by modulating the activities of protein kinases in its target tissues: muscle, liver and fat. Defects in insulin's ability to modulate protein kinase activity lead to ‘insulin resistance’ or impaired insulin action. Insulin resistance in combination with defective insulin secretion from the pancreas results in the elevated blood glucose levels that are characteristic of diabetes mellitus. Pharmacological agents that selectively modulate protein kinase activities in insulin-resistant tissues may act either as insulin-sensitizing or insulin-mimetic drugs. Consistent with this, small molecule modulators of a number of protein kinases have demonstrated efficacy in animal models of insulin resistance and diabetes. Moreover, emerging data in humans suggest that marketed anti-diabetic agents may also act in part through modulating protein kinase activities. This meeting was convened to consider the potential to treat insulin resistance and Type II diabetes by modulating protein kinase activity.
Skip Nav Destination
Article navigation
April 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Conference Article|
April 01 2005
Introduction to the Kinases in Diabetes Biochemical Society focused meeting: are protein kinases good targets for antidiabetic drugs?
M.P. Coghlan;
M.P. Coghlan
1
1AstraZeneca, Diabetes Drug Discovery, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.
1To whom correspondence should be addressed (email matthew.coghlan@astrazeneca.com).
Search for other works by this author on:
D.M. Smith
D.M. Smith
1AstraZeneca, Diabetes Drug Discovery, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
January 27 2005
Online ISSN: 1470-8752
Print ISSN: 0300-5127
© 2005 The Biochemical Society
2005
Biochem Soc Trans (2005) 33 (2): 339–342.
Article history
Received:
January 27 2005
Citation
M.P. Coghlan, D.M. Smith; Introduction to the Kinases in Diabetes Biochemical Society focused meeting: are protein kinases good targets for antidiabetic drugs?. Biochem Soc Trans 1 April 2005; 33 (2): 339–342. doi: https://doi.org/10.1042/BST0330339
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.